Applicant, as named in the Orange Book

Endo Operations

Next listed expiry: Aveed on 8 May 2027. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Aveed testosterone undecanoate	testosterone undecanoate	022219	8 May 2027	patent, carve-out possible

Recent events

24 Oct 2026Sumavel Dosepro · Enters 12-month window basis: patent22 Nov 2026
24 Oct 2026Aveed · Enters 12-month window basis: patent, carve-out possible8 May 2027

Products without listed protection (4)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Edex · 6 strengths alprostadil	alprostadil	020649	open now	no listed protection
Supprelin La histrelin acetate	histrelin acetate	022058	open now	no listed protection
Testim testosterone	testosterone	021454	open now	no listed protection
Valstar Preservative Free valrubicin	valrubicin	020892	open now	no listed protection